Stock Market Today: Stocks Drop on Troubling China Data, Bank Ratings Worries
The main benchmarks fell Tuesday, but healthcare stocks outperformed as Eli Lilly and Novo Nordisk surged.
Tuesday was a down day on Wall Street with stocks getting walloped across the board. Concerns over China's economy and the possibility that several big U.S. banks could see their credit ratings downgraded weighed on sentiment.
While the selling pressure was widespread for most of the session, healthcare stocks outperformed thanks to a few big movers.
Overnight, data from China showed exports from the world's second-largest economy fell 14.5% year-over-year in July, while imports dropped 12.4%.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"The trade data from China was undoubtedly disappointing as it once again showed sluggish demand both domestically and externally," says Craig Erlam, senior market analyst at OANDA. China's economy is clearly in need of a boost, but it's likely authorities will engage in small, targeted measures that won't boost confidence among investors or households, Erlam adds.
Moody's lowers credit ratings for regional lenders, puts bigger banks under review
Meanwhile, Moody's Investors Services late Monday lowered the credit ratings for several regional lenders, including Pinnacle Financial Partners (PNFP, -2.1%) and M&T Bank (MTB, -1.5%). The ratings agency also said it is reviewing ratings for a number of larger U.S. banks, including Bank of New York Mellon (BK, -1.3%) and State Street (STT, -1.6%). The news sent shockwaves through the financial sector, with Goldman Sachs (GS, -2.1%) and JPMorgan Chase (JPM, -0.6%) being two of the worst Dow Jones stocks today.
"The development, which comes roughly five months after a handful of regional banks hit the skids, has sparked renewed concerns about the potential for additional bank failures and consolidations," says José Torres, senior economist at Interactive Brokers.
Additionally, the headlines hit as investors are trying to determine whether or not the Federal Reserve will continue to raise interest rates. "To that end, the Consumer Price Index (CPI) data to be released this Thursday could be a significant driver of investor sentiment and the outlook for the Fed's monetary policy," Torres adds.
Eli Lilly, Novo Nordisk pop on weight-loss drug news
Investors also took in the latest batch of earnings reports. On the positive side of the ledger, Eli Lilly (LLY) popped 14.9% after the drugmaker reported higher-than-expected second-quarter earnings of $2.11. Plus, revenue of $8.3 billion beat estimates thanks in part to strong sales of Eli Lilly's diabetes drug Mounjaro. LLY also got a boost after Novo Nordisk (NVO, +17.2%) said its obesity drug Wegovy reduced the chance of heart attacks by 20% in subjects who participated in a trial.
The data removes an "overhang" for the obesity treatment landscape, says BofA Securities analyst Geoff Meacham. The analyst, who reiterated his Buy rating on LLY, added that "today's results bolsters our confidence in the obesity commercial opportunity."
At the other end of the spectrum, Beyond Meat (BYND) tumbled 14.3% after the plant-based protein maker reported earnings. While the company reported a narrower-than-expected second-quarter loss of 83 cents per share, revenue of $102.1 million – down 30% on a year-over-year basis – came in below estimates. BYND also gave lower-than-anticipated full-year revenue guidance.
As for the major indexes, while they finished well off their intraday lows, the blue chip Dow Jones Industrial Average still closed down 0.5% to 35,314. The broader S&P 500 shed 0.4% to 4,499, and the tech-heavy Nasdaq Composite fell 0.8% to 13,884.
Related Content
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
How to Retire Early by 40: Build the FIRE Now
It's not easy, but you may be able to retire by 40 or 45 if you take these FIRE (Financial Independence, Retire Early) steps now.
By Jacob Schroeder Published
-
If You’re Preparing to Move, Should You Buy or Rent?
Both prospects are expensive these days, but there are several questions you can ask yourself to help you decide what’s right for you.
By Justin Stivers, Esq. Published
-
Stock Market Today: Markets Soar Amid Strong Earnings for Big Tech
Equities ended the week on an up note thanks to some of the market's biggest names.
By Dan Burrows Published
-
Stock Market Today: Markets Tumble Amid Slower Economic Growth and Rising Prices
Disappointing readings on GDP and inflation helped tank equities.
By Dan Burrows Published
-
Stock Market Today: Stocks Run Out of Steam Ahead of Meta Earnings
The Dow Jones Industrial Average snapped a four-day winning streak after Boeing's first-quarter results.
By Karee Venema Published
-
Stock Market Today: Nasdaq Soars Ahead of Tesla Earnings
The EV stock rose nearly 2% ahead of its highly anticipated Q1 earnings report, due after tonight's close.
By Karee Venema Published
-
Stock Market Today: Markets Rebound Ahead of Big Week for Earnings
Equities rallied on easing geopolitical tensions, upcoming quarterly results.
By Dan Burrows Published
-
Stock Market Today: Nasdaq Spirals as Netflix Nosedives
A big earnings boom for credit card giant American Express helped the Dow notch another win.
By Karee Venema Published
-
Stock Market Today: S&P 500, Nasdaq Extend Losing Streaks
The two indexes have closed lower for five straight sessions.
By Karee Venema Published
-
Stock Market Today: Dow Slips After Travelers' Earnings Miss
The property and casualty insurer posted a bottom-line miss as catastrophe losses spiked.
By Karee Venema Published